A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers
Clinical trial NCT06672900 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06672900
- Sponsor
- Aligos Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2025-07-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.